| Net income | -396.8M |
| Depreciation and amortization | 44.5M |
| Amortization of discount on convertible notes | 2.8M |
| Impairment of long-lived assets | |
| Stock-based compensation | 5.2M |
| Other non-cash items | 8.2M |
| Accounts and notes receivable | 2M |
| Inventories | 140.9M |
| Other current assets | -13.2M |
| Accounts payable, accrued expenses, income taxes payable and other | |
| Net cash provided by operating activities | -242.9M |
| Additions to property, plant and equipment | -39.8M |
| Proceeds from sale of property, plant and equipment | 0 |
| Net cash used in investing activities | -36.7M |
| Issuance of long-term notes | 650.5M |
| Long-term notes issuance costs | -33.8M |
| Repayments of borrowings | |
| Purchases of treasury stock | |
| Changes in cash overdrafts | 17.3M |
| Proceeds from exercise of stock options | |
| Net cash (used in) provided by financing activities | 213.3M |
| Net (decrease) increase in cash and cash equivalents | -66.3M |
| Cash and cash equivalents, beginning of period | 109.6M |
| Cash and cash equivalents, end of period | 43.3M |